A PYMNTS Company

Johnson & Johnson offers concessions for EU to approve Synthes acquisition

By  |  February 22, 2012

Johnson & Johnson has offered concessions to gain EU approval for its planned acquisition of Synthes. Johnson & Johnson is the world’s second-largest seller of health products and Synthes manufactures medical tools. The $18.89 billion deal would make Johnson & Johnson the market leader in devices for trauma victims. No further details are available on the offered concessions.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The European Commission will rule on the acquisition by April 26.

    Source: Bloomberg

     

    Related content: Analyzing Medical Device Mergers